Pimavanserin tartrate is a tartrate salt that is the hemitartrate salt of pimavanserin. An atypical antipsychotic that is used for treatment of hallucinations and delusions associated with Parkinson’s disease. Its therapeutic use is listed as antipsychotics. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Nuplazid and pimavanserin hemitartrate. Its PubChem CID is 11672491.
Pimavanserin tartrate
| CAS No | 706782-28-7 |
|---|---|
| Molecular Formula | C54H74F2N6O10 |
| Molecular Weight | 1005.2 g/mol |
| Synonyms | (2R,3R)-2,3-dihydroxybutanedioic acid;1-[(4-fluorophenyl)methyl]-1-(1-methylpiperidin-4-yl)-3-[[4-(2-methylpropoxy)phenyl]methyl]urea |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Pimavanserin tartrate is a tartrate salt that is the hemitartrate salt of pimavanserin. An atypical antipsychotic that is used for treatment of hallucinations and delusions associated with Parkinson's disease.
The listed CAS number is 706782-28-7.
The listed molecular formula is C54H74F2N6O10.
The listed molecular weight is 1005.2 g/mol.
(2R,3R)-2,3-dihydroxybutanedioic acid;1-[(4-fluorophenyl)methyl]-1-(1-methylpiperidin-4-yl)-3-[[4-(2-methylpropoxy)phenyl]methyl]urea.
The source lists Nuplazid and pimavanserin hemitartrate.